Mohammad Naraghi
Panel: Tech Companies Reaching the Consumer – Both Healthcare & Non‐Healthcare MarketsProfessor Jeffrey Moe joined the Health Sector Management program, the Fuqua School of Business, in 2001. His research interests include new incentives for innovation in neglected tropical and infectious disease research, private sector responses to the global health care worker shortage and the use of business intelligence as a basis of competitive advantage among life sciences firms. He is a Visiting Lecturer in the School of Public Health in the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jeff was co-author of “Developing Drugs for Developing Countries” (Health Affairs, March/April 2006) which led to the Sec. 524 amendment in the Food and Drug Administration Amendments Act of 2007. The article recommended, and the legislation now makes into law, a new incentive for neglected tropical disease medicines: the priority review voucher (PRV). A PRV is awarded for US registration of a new medicine (new chemical, biological or diagnostic) for a tropical disease (16 diseases including TB and malaria), the “tropical drug.” The voucher is exercised by receiving priority review of a second drug, the “voucher drug”, for FDA approval to market to US patients. The FDA issued its guidance in October, 2008 to administer the new voucher program and the first tropical drug applications for the new voucher program could be submitted beginning September 28, 2008.
Professor Moe is the Director, Private Sector Task Force (PSTF) which operates under the aegis of the Global Health Workforce Alliance (managed by the WHO). The PSTF Secretariat is housed here at the Duke Global Health Institute where he is an affiliate faculty member. The PSTF identifies and promotes the expansion of private sector initiatives which are increasing the supply, effectiveness and retention of health care workers. In his role Jeff leads the research and administration of the Technical Working Group which carries out analysis, interventions and evaluation for the PSTF. The PSTF is laying the groundwork for the introduction of a social/business “incubator” to increase the scaling and cross-border movement of effective private sector responses to the worker shortage. PSTF has identified health workforce innovators which are demonstrating private sector approaches to the human resources for health crisis. The PSTF will release a report on its activities in December 2010.
Jeff’s recent work includes a paper on private sector responses to the health worker shortage (“Private Health Sector Innovation in Response to the Human Resources for Health Global Crisis”), policy and economic considerations for “chemopreventative agents” (“Impact of Economic, Regulatory and Patent Policies on Innovation in Cancer Chemoprevention” http://www.econ.duke.edu/Papers/PDF/BarrierWorkingPaper.pdf.) and a descriptive case study of the King Hussein Cancer Center (“Transformational leadership, transnational culture and political competence in globalizing health care services: a case study of Jordan’s King Hussein Cancer Center” Globalization and Health, November 2007).
Jeff teaches the HSM seminar series, a required course for the HSM certificate, for daytime and executive students. With Professors Will Mitchell and David Ridley he co-teaches HLTHMGMT 409 which gives our students insights into strategy and economics of the biopharma industry. Before coming to Duke, Jeff was an executive at GlaxoSmithKline. Over a 15-year career he held positions in business development, corporate strategy, marketing, market economics and human resources. He received his Ph.D. in 1981 from the University of North Carolina at Chapel Hill in Organization Development and Behavior. He graduated from the Kellogg School, Northwestern University, Executive Development Program in 1997.Stephen Savas is a Principal in McKinsey & Company’s Business Technology Office and is based in Florham Park, New Jersey. He joined the firm in 2007 and is a leader in the healthcare information technology practice with 20+ years of experience, including 15 years in healthcare IT. Steve leads our internal research for The McKinsey Health Informatics Initiative and a Special Initiative on Global HIT Impact on Healthcare. His work includes healthcare IT related studies for a variety of stakeholders – payors, providers, pharmacos, technology vendors and governments.
Dr. Mohammad Naraghi is IBM’s Global Healthcare Industry Leader at Global Business Services Unit (GBS). In this capacity, he is in charge of developing the global business in Healthcare and building and expanding IBM’s relationships with its clients. He has rich experience gained from almost 20 years in the Healthcare and Life Sciences industry. Prior to joining IBM, Dr. Naraghi worked for Siemens AG and McKinsey & Company. |
